|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/47 | |
| A61K 9/00 | |||
| G01N 33/538 | |||
| A61P 3/00 | |||
| A61P 43/00 | |||
| G01N 33/68 |
| (11) | Number of the document | 2863941 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13755466.3 |
| Date of filing the European patent application | 2013-03-01 | |
| (97) | Date of publication of the European application | 2015-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-12-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/028608 |
| Date | 2013-03-01 |
| (87) | Number | WO 2013/130963 |
| Date | 2013-09-06 |
| (30) | Number | Date | Country code |
| 201261606089 P | 2012-03-02 | US |
| (72) |
CROMBEZ, Eric, US
BHIRANGI, Kiran, US
COHN, Gabriel, Martin, US
|
| (73) |
Shire Human Genetic Therapies, Inc.,
300 Shire Way, Lexington MA 02421,
US
|
| (54) | VELAGLUCERASE FOR TREATING TYPE III GAUCHER DISEASE |
| VELAGLUCERASE FOR TREATING TYPE III GAUCHER DISEASE |